litlas
ログインアカウント作成

Lauren E. Abrey

1998–2022 年に発表

97
論文数
22,835
被引用数
82
h 指数
97
i10 指数

被引用数

Lauren E. Abrey の年別被引用数1999 年: 被引用 7 件2000 年: 被引用 10 件2001 年: 被引用 11 件2002 年: 被引用 26 件2003 年: 被引用 32 件2004 年: 被引用 38 件2005 年: 被引用 48 件2006 年: 被引用 77 件2007 年: 被引用 116 件2008 年: 被引用 144 件2009 年: 被引用 228 件2010 年: 被引用 284 件2011 年: 被引用 278 件2012 年: 被引用 233 件2013 年: 被引用 223 件2014 年: 被引用 261 件2015 年: 被引用 251 件2016 年: 被引用 235 件2017 年: 被引用 268 件2018 年: 被引用 208 件2019 年: 被引用 576 件2020 年: 被引用 684 件2021 年: 被引用 583 件2022 年: 被引用 412 件2023 年: 被引用 315 件2024 年: 被引用 427 件2025 年: 被引用 164 件2026 年: 被引用 5 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,918 件、この内訳の 30.6%ドイツ: 引用元論文 529 件、この内訳の 8.5%中国: 引用元論文 412 件、この内訳の 6.6%イギリス: 引用元論文 330 件、この内訳の 5.3%フランス: 引用元論文 322 件、この内訳の 5.1%イタリア: 引用元論文 322 件、この内訳の 5.1%スイス: 引用元論文 266 件、この内訳の 4.2%オランダ: 引用元論文 241 件、この内訳の 3.8%カナダ: 引用元論文 198 件、この内訳の 3.2%日本: 引用元論文 167 件、この内訳の 2.7%スペイン: 引用元論文 142 件、この内訳の 2.3%オーストラリア: 引用元論文 135 件、この内訳の 2.2%
0%30.6%その他 20.4%

機関

分野

  • Medicine78.9%
  • Biochemistry, Genetics and Molecular Biology11.2%
  • Neuroscience2.8%
  • Immunology and Microbiology2.7%
  • Materials Science1.4%
  • Engineering1.1%
  • その他1.9%

トピック

  • Glioma Diagnosis and Treatment19.3%
  • Brain Metastases and Treatment7.9%
  • CNS Lymphoma Diagnosis and Treatment4.9%
  • Lymphoma Diagnosis and Treatment4.2%
  • Meningioma and schwannoma management2.7%
  • Cancer, Hypoxia, and Metabolism2.3%
  • その他58.7%

共著者

全論文

検索で開く
  1. Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

    著者: Olivier Chinot, Wolfgang Wick, Warren Mason, Roger Henriksson, Frank Saran, Ryo Nishikawa, Alain Carpentier, Khê Hoang‐Xuan, Petr Kavan, Dana Cernea, Alba A. Brandes, Magalie Hilton, Lauren E. Abrey, Timothy F. Cloughesy - New England Journal of Medicine 2014 被引用: 2,503

  2. Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

    著者: Henry S. Friedman, Michael D. Prados, Patrick Y. Wen, Tom Mikkelsen, David Schiff, Lauren E. Abrey, W.K. Alfred Yung, Nina A. Paleologos, M. Kelly Nicholas, Randy L. Jensen, James J. Vredenburgh, Jane Huang, Maoxia Zheng, Timothy F. Cloughesy - Journal of Clinical Oncology 2009 被引用: 2,444

  3. Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

    著者: Lauren E. Abrey, Tracy T. Batchelor, Andrés J.M. Ferreri, Mary Gospodarowicz, Elisa Jacobsen Pulczynski, Emanuele Zucca, Justine R. Smith, Agnieszka Korfel, Carole Soussain, Lisa M. DeAngelis, Edward A. Neuwelt, Brian Patrick O’Neill, Eckhard Thiel, Tamara Shenkier, Francesc Graus, Martin J. van den Bent, John F. Seymour, Philip Poortmans, Jamés O. Armitage, Franco Cavalli - Journal of Clinical Oncology 2005 被引用: 906

  4. Primary Central Nervous System Lymphoma: The Memorial Sloan-Kettering Cancer Center Prognostic Model

    著者: Lauren E. Abrey, Leah Ben‐Porat, Katherine S. Panageas, Joachim Yahalom, Brian Berkey, Walter J. Curran, Christopher J. Schultz, Steven A. Leibel, Diana F. Nelson, Minesh P. Mehta, Lisa M. DeAngelis - Journal of Clinical Oncology 2006 被引用: 620

  5. Leveraging external data in the design and analysis of clinical trials in neuro-oncology

    著者: Rifaquat Rahman, Steffen Ventz, Jon McDunn, Bill Louv, Irmarie Reyes‐Rivera, Mei‐Yin C. Polley, Fahar Merchant, Lauren E. Abrey, Joshua E. Allen, Laura K. Aguilar, Estuardo Aguilar-Córdova, David Arons, Kirk Tanner, Stephen Bagley, Mustafa Khasraw, Timothy F. Cloughesy, Patrick Y. Wen, Brian M. Alexander, Lorenzo Trippa - The Lancet Oncology 2021 被引用: 84

  6. R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma

    著者: Antonio Omuro, Denise D. Correa, Lisa M. DeAngelis, Craig H. Moskowitz, Matthew J. Matasar, Thomas Kaley, Igor T. Gavrilovic, Craig Nolan, Elena Pentsova, Christian Grommes, Katherine S. Panageas, Raymond E. Baser, Géraldine Faivre, Lauren E. Abrey, Craig S. Sauter - Blood 2015 被引用: 345

  7. Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

    著者: Patrick G. Morris, Denise D. Correa, Joachim Yahalom, Jeffrey J. Raizer, David Schiff, Barbara Grant, Sean Grimm, Rose Lai, Anne S. Reiner, K. Panageas, Sasan Karimi, Richard Curry, Gaurav Shah, Lauren E. Abrey, Lisa M. DeAngelis, Antonio Omuro - Journal of Clinical Oncology 2013 被引用: 491

  8. Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas

    著者: Kathleen R. Lamborn, W.K. Alfred Yung, Susan M. Chang, Patrick Y. Wen, Timothy F. Cloughesy, Lisa M. DeAngelis, H. Ian Robins, Frank S. Lieberman, Howard A. Fine, Karen Fink, Larry Junck, Lauren E. Abrey, Mark R. Gilbert, Minesh P. Mehta, John G. Kuhn, Kenneth Aldape, Janelle L. Hibberts, Pamela Peterson, Michael D. Prados - Neuro-Oncology 2008 被引用: 422

  9. Strategies to advance translational research into brain barriers

    著者: Edward A. Neuwelt, N. Joan Abbott, Lauren E. Abrey, William A. Banks, Brian W. Blakley, Thomas P. Davis, Britta Engelhardt, Paula Grammas, Maiken Nedergaard, John G. Nutt, William M. Pardridge, Gary A. Rosenberg, Quentin R. Smith, Lester R. Drewes - The Lancet Neurology 2008 被引用: 469

  10. Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial

    著者: Thomas Sandmann, Richard Bourgon, Josep Garcia, Congfen Li, Timothy F. Cloughesy, Olivier Chinot, Wolfgang Wick, Ryo Nishikawa, Warren Mason, Roger Henriksson, Frank Saran, Albert Lai, N. Moore, Samir Kharbanda, Franklin Peale, Priti S. Hegde, Lauren E. Abrey, Heidi Phillips, Carlos Bais - Journal of Clinical Oncology 2015 被引用: 293

  11. Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma

    著者: Thomas Kaley, Patrick Y. Wen, David Schiff, Keith L. Ligon, Sam Haidar, Sasan Karimi, Andrew B. Lassman, Craig Nolan, Lisa M. DeAngelis, Igor T. Gavrilovic, Andrew D. Norden, Jan Drappatz, Eudocia Q. Lee, Benjamin Purow, Scott R. Plotkin, Tracy T. Batchelor, Lauren E. Abrey, Antonio Omuro - Neuro-Oncology 2014 被引用: 289

  12. Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)

    著者: Fábio M. Iwamoto, Kathleen R. Lamborn, H. I. Robins, Minesh P. Mehta, Shannon Chang, Nicholas Butowski, Lisa M. DeAngelis, Lauren E. Abrey, Wei Zhang, Michael D. Prados, H. A. Fine - Neuro-Oncology 2010 被引用: 219

  13. Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma

    著者: Thomas Kaley, Katherine S. Panageas, Ingo K. Mellinghoff, Craig Nolan, Igor T. Gavrilovic, Lisa M. DeAngelis, Lauren E. Abrey, Eric C. Holland, Andrew B. Lassman - Journal of Neuro-Oncology 2019 被引用: 62

  14. Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma

    著者: Jacques Grill, Maura Massimino, Éric Bouffet, Amedeo A. Azizi, Geoffrey McCowage, Adela Cañete, Frank Saran, Marie‐Cécile Le Deley, Pascale Varlet, Paul S. Morgan, Tim Jaspan, Chris Jones, Felice Giangaspero, Helen Smith, Josep Garcia, Markus C. Elze, Raphaël F. Rousseau, Lauren E. Abrey, Darren Hargrave, Gilles Vassal - Journal of Clinical Oncology 2018 被引用: 140

  15. Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma

    著者: Benjamin M. Ellingson, Lauren E. Abrey, Sarah J. Nelson, Timothy J. Kaufmann, Josep Garcia, Olivier Chinot, Frank Saran, Ryo Nishikawa, Roger Henriksson, W. P. Mason, Wolfgang Wick, Nicholas Butowski, Keith L. Ligon, Elizabeth R. Gerstner, Howard Colman, John de Groot, Susan M. Chang, Ingo K. Mellinghoff, Robert J. Young, Brian M. Alexander, Rivka R. Colen, Jennie Taylor, Isabel Arrillaga‐Romany, Arnav Mehta, Raymond Y. Huang, Whitney B. Pope, David A. Reardon, Tracy T. Batchelor, Michael D. Prados, Evanthia Galanis, Patrick Y. Wen, Timothy F. Cloughesy - Neuro-Oncology 2018 被引用: 96

  16. Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma

    著者: Thomas Kaley, Katherine S. Panageas, Elena Pentsova, Ingo K. Mellinghoff, Craig Nolan, Igor T. Gavrilovic, Lisa M. DeAngelis, Lauren E. Abrey, Eric C. Holland, Antonio Omuro, Mario E. Lacouture, Emmy Ludwig, Andrew B. Lassman - Annals of Clinical and Translational Neurology 2020 被引用: 46

  17. Combined Immunochemotherapy With Reduced Whole-Brain Radiotherapy for Newly Diagnosed Primary CNS Lymphoma

    著者: Gaurav Shah, Joachim Yahalom, Denise D. Correa, Rose Lai, Jeffrey J. Raizer, David Schiff, Renato V. LaRocca, Barbara Grant, Lisa M. DeAngelis, Lauren E. Abrey - Journal of Clinical Oncology 2007 被引用: 403

  18. Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab

    著者: Patrick Großmann, Vivek Narayan, Ken Chang, Rifaquat Rahman, Lauren E. Abrey, David A. Reardon, Lawrence H. Schwartz, Patrick Y. Wen, Brian M. Alexander, Raymond Y. Huang, Hugo J.W.L. Aerts - Neuro-Oncology 2017 被引用: 111

  19. Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial

    著者: Hans‐Georg Wirsching, Ghazaleh Tabatabai, Ulrich Roelcke, Andreas F. Hottinger, Francisca Jörger, Andrea Schmid, Ludwig Plaßwilm, Daniel Schrimpf, Christoph Mancao, David Capper, Katrin Conen, Thomas Hundsberger, Francesca Caparrotti, Roger von Moos, Christian Riklin, Jörg Felsberg, Patrick Roth, David Jones, Stefan M. Pfister, Elisabeth J. Rushing, Lauren E. Abrey, Guido Reifenberger, Leonhard Held, Andreas von Deimling, Adrian F. Ochsenbein, Michael Weller - Annals of Oncology 2018 被引用: 86

  20. Safety and Efficacy of Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas

    著者: Philip H. Gutin, Fábio M. Iwamoto, Kathryn Beal, Nimish Mohile, Sasan Karimi, Bob L. Hou, Stella Lymberis, Yoshiya Yamada, Jenghwa Chang, Lauren E. Abrey - International Journal of Radiation Oncology*Biology*Physics 2009 被引用: 373

  21. Phase I Study of Intraventricular Administration of Rituximab in Patients With Recurrent CNS and Intraocular Lymphoma

    著者: James L. Rubenstein, Jane Fridlyand, Lauren E. Abrey, Arthur Shen, Jon Karch, Endi Wang, Samar Issa, Lloyd E. Damon, Michael D. Prados, Michael McDermott, Joan M. O’Brien, Chris Haqq, Marc Shuman - Journal of Clinical Oncology 2007 被引用: 325

  22. Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report

    著者: Sean Grimm, José S. Pulido, Kristoph Jahnke, David Schiff, Anthony Hall, Tamara Shenkier, T. Siegal, Nancy D. Doolittle, Tracy T. Batchelor, Ulrich Herrlinger, Edward A. Neuwelt, Normand Laperrière, Marc C. Chamberlain, Jean‐Yves Blay, Andrés J.M. Ferreri, Antonio Omuro, E. Thiel, Lauren E. Abrey - Annals of Oncology 2007 被引用: 287

  23. Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma

    著者: Andrew D. Norden, Jeffrey J. Raizer, Lauren E. Abrey, Kathleen R. Lamborn, Andrew B. Lassman, Susan M. Chang, W.K. Alfred Yung, Mark R. Gilbert, Howard A. Fine, Minesh P. Mehta, Lisa M. DeAngelis, Timothy F. Cloughesy, H. Ian Robins, Kenneth Aldape, Janet Dancey, Michael D. Prados, Frank S. Lieberman, Patrick Y. Wen - Journal of Neuro-Oncology 2009 被引用: 196

  24. Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials

    著者: Kelong Han, Min Ren, Wolfgang Wick, Lauren E. Abrey, Arabinda K. Das, James Jin, David A. Reardon - Neuro-Oncology 2013 被引用: 142